Chlorine in PDB 6cwk: Anti-Rta Vhh Antibody
Protein crystallography data
The structure of Anti-Rta Vhh Antibody, PDB code: 6cwk
was solved by
M.J.Rudolph,
N.Mantis,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
37.77 /
1.26
|
Space group
|
P 43 21 2
|
Cell size a, b, c (Å), α, β, γ (°)
|
60.294,
60.294,
81.389,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
15.5 /
17.6
|
Chlorine Binding Sites:
The binding sites of Chlorine atom in the Anti-Rta Vhh Antibody
(pdb code 6cwk). This binding sites where shown within
5.0 Angstroms radius around Chlorine atom.
In total 2 binding sites of Chlorine where determined in the
Anti-Rta Vhh Antibody, PDB code: 6cwk:
Jump to Chlorine binding site number:
1;
2;
Chlorine binding site 1 out
of 2 in 6cwk
Go back to
Chlorine Binding Sites List in 6cwk
Chlorine binding site 1 out
of 2 in the Anti-Rta Vhh Antibody
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 1 of Anti-Rta Vhh Antibody within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl205
b:80.5
occ:1.00
|
H
|
A:GLY68
|
2.0
|
37.0
|
1.0
|
O
|
A:HOH431
|
2.6
|
48.2
|
1.0
|
O
|
A:HOH403
|
2.6
|
25.9
|
1.0
|
N
|
A:GLY68
|
2.8
|
30.9
|
1.0
|
HA2
|
A:GLY68
|
2.8
|
38.4
|
1.0
|
HB3
|
A:TYR62
|
3.0
|
18.6
|
1.0
|
CA
|
A:GLY68
|
3.3
|
31.9
|
1.0
|
HB2
|
A:MET66
|
3.4
|
71.2
|
1.0
|
O
|
A:ALA63
|
3.4
|
24.3
|
1.0
|
HB2
|
A:TYR62
|
3.5
|
18.6
|
1.0
|
H
|
A:GLN67
|
3.5
|
47.4
|
1.0
|
N
|
A:GLN67
|
3.6
|
39.4
|
1.0
|
CB
|
A:TYR62
|
3.6
|
15.5
|
1.0
|
O
|
A:HOH423
|
3.7
|
52.0
|
1.0
|
C
|
A:MET66
|
3.8
|
62.9
|
1.0
|
H
|
A:MET66
|
3.9
|
74.3
|
1.0
|
C
|
A:GLN67
|
3.9
|
32.8
|
1.0
|
HA3
|
A:GLY68
|
4.0
|
38.4
|
1.0
|
H
|
A:ARG69
|
4.1
|
32.8
|
1.0
|
CB
|
A:MET66
|
4.2
|
59.3
|
1.0
|
O
|
A:HOH408
|
4.2
|
59.3
|
1.0
|
CG
|
A:TYR62
|
4.2
|
14.1
|
1.0
|
O
|
A:MET66
|
4.2
|
34.7
|
1.0
|
CA
|
A:GLN67
|
4.3
|
34.6
|
1.0
|
C
|
A:GLY68
|
4.3
|
37.4
|
1.0
|
HA
|
A:ASP64
|
4.3
|
39.9
|
1.0
|
CA
|
A:MET66
|
4.3
|
69.0
|
1.0
|
H
|
A:PHE70
|
4.5
|
23.0
|
0.4
|
HA
|
A:GLN67
|
4.5
|
41.6
|
1.0
|
N
|
A:MET66
|
4.5
|
61.9
|
1.0
|
H
|
A:PHE70
|
4.5
|
24.3
|
0.6
|
N
|
A:ARG69
|
4.5
|
27.3
|
1.0
|
C
|
A:ALA63
|
4.6
|
22.3
|
1.0
|
HD1
|
A:TYR62
|
4.6
|
16.9
|
1.0
|
HB3
|
A:MET66
|
4.6
|
71.2
|
1.0
|
O
|
A:ASP64
|
4.6
|
39.8
|
1.0
|
CD1
|
A:TYR62
|
4.7
|
14.1
|
1.0
|
O
|
A:HOH410
|
4.7
|
57.4
|
1.0
|
C
|
A:ASP64
|
4.9
|
40.2
|
1.0
|
O
|
A:HOH421
|
4.9
|
74.7
|
1.0
|
HB2
|
A:PHE70
|
4.9
|
23.1
|
0.4
|
CA
|
A:ASP64
|
5.0
|
33.2
|
1.0
|
CD2
|
A:TYR62
|
5.0
|
14.2
|
1.0
|
CA
|
A:TYR62
|
5.0
|
13.8
|
1.0
|
HD2
|
A:PHE70
|
5.0
|
22.8
|
0.4
|
|
Chlorine binding site 2 out
of 2 in 6cwk
Go back to
Chlorine Binding Sites List in 6cwk
Chlorine binding site 2 out
of 2 in the Anti-Rta Vhh Antibody
Mono view
Stereo pair view
|
A full contact list of Chlorine with other atoms in the Cl binding
site number 2 of Anti-Rta Vhh Antibody within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:Cl206
b:55.1
occ:1.00
|
H
|
A:ASP113
|
2.2
|
22.6
|
0.4
|
H
|
A:ASP113
|
2.2
|
22.6
|
0.6
|
O
|
A:HOH386
|
2.9
|
43.9
|
1.0
|
O
|
A:HOH419
|
3.0
|
42.1
|
1.0
|
HA
|
A:SER112
|
3.0
|
17.1
|
0.6
|
N
|
A:ASP113
|
3.0
|
18.8
|
1.0
|
HA
|
A:SER112
|
3.0
|
19.9
|
0.4
|
O
|
A:HOH406
|
3.1
|
50.8
|
1.0
|
HB3
|
A:ASP113
|
3.3
|
21.1
|
1.0
|
O
|
A:SER111
|
3.3
|
16.5
|
1.0
|
O
|
A:HOH316
|
3.3
|
51.6
|
1.0
|
OD1
|
A:ASP113
|
3.4
|
25.2
|
1.0
|
HE2
|
A:PHE37
|
3.4
|
15.6
|
1.0
|
CG
|
A:ASP113
|
3.4
|
21.4
|
1.0
|
CB
|
A:ASP113
|
3.7
|
17.6
|
1.0
|
OD2
|
A:ASP113
|
3.8
|
25.7
|
1.0
|
CA
|
A:SER112
|
3.8
|
14.2
|
0.6
|
CA
|
A:SER112
|
3.8
|
16.6
|
0.4
|
C
|
A:SER112
|
3.9
|
17.2
|
0.6
|
C
|
A:SER112
|
3.9
|
14.0
|
0.4
|
CA
|
A:ASP113
|
3.9
|
16.4
|
1.0
|
CE2
|
A:PHE37
|
4.3
|
13.0
|
1.0
|
C
|
A:SER111
|
4.3
|
14.2
|
1.0
|
HG
|
A:SER112
|
4.4
|
24.2
|
0.6
|
HA
|
A:ASP113
|
4.5
|
19.7
|
1.0
|
N
|
A:SER112
|
4.5
|
13.6
|
0.6
|
O
|
A:ARG45
|
4.6
|
18.0
|
1.0
|
N
|
A:SER112
|
4.6
|
15.0
|
0.4
|
HB2
|
A:ASP113
|
4.6
|
21.1
|
1.0
|
H
|
A:ARG114
|
4.7
|
24.2
|
1.0
|
HD2
|
A:PHE37
|
4.7
|
14.4
|
1.0
|
OG
|
A:SER112
|
4.9
|
20.1
|
0.6
|
HG
|
A:SER112
|
4.9
|
27.1
|
0.4
|
CB
|
A:SER112
|
5.0
|
16.4
|
0.6
|
O
|
A:HOH394
|
5.0
|
24.1
|
1.0
|
HB3
|
A:SER112
|
5.0
|
27.1
|
0.4
|
HB2
|
A:PHE47
|
5.0
|
15.3
|
1.0
|
HB2
|
A:ARG45
|
5.0
|
17.3
|
1.0
|
CD2
|
A:PHE37
|
5.0
|
12.0
|
1.0
|
HZ
|
A:PHE37
|
5.0
|
15.1
|
1.0
|
CB
|
A:SER112
|
5.0
|
22.6
|
0.4
|
H
|
A:PHE47
|
5.0
|
15.8
|
1.0
|
|
Reference:
M.J.Rudolph,
D.J.Vance,
S.Kelow,
S.K.Angalakurthi,
S.Nguyen,
S.A.Davis,
Y.Rong,
C.R.Middaugh,
D.D.Weis,
R.Dunbrack Jr.,
J.Karanicolas,
N.J.Mantis.
Contribution of An Unusual CDR2 Element of A Single Domain Antibody in Ricin Toxin Binding Affinity and Neutralizing Activity. Protein Eng. Des. Sel. V. 31 277 2018.
ISSN: ESSN 1741-0134
PubMed: 30265352
DOI: 10.1093/PROTEIN/GZY022
Page generated: Sat Jul 27 21:13:03 2024
|